This study by PATH's Japanese encephalitis (JE) project evaluated whether measles vaccine and the live, attenuated JE vaccine can be safely co-administered with no effect on the immunogenicity of either.
Author(s): Gatchalian S, Jacobson J, Kelly K, Sutee Y, Yaïch M, Yao Y, Zhang L, Zhou B
Corporate author(s): PATH
Publication date: December 2006
708 KB PDF
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA